Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AVXL)

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

GlobeNewswire 2 days ago

Anavex Life Sciences Corporation Class Action: Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL

Accesswire 3 days ago

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $500,000 to Contact the Firm

Accesswire 3 days ago

Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class Action - AVXL

Accesswire 3 days ago

Faruqi & Faruqi, LLP Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024

Newsfile 3 days ago

Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Accesswire 3 days ago

AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire 3 days ago

Investors who lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class Action - AVXL

Accesswire 3 days ago

Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

PR Newswire 3 days ago
View More News ››

Opinion & Analysis (NDAQ:AVXL)

Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's

Streetwise Reports December 11, 2019

EMA Opinion Bodes Well for Biopharma's Drug Getting Orphan Status

Streetwise Reports August 1, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AVXL)

Not a lot of respect here….

For their data.  Seems like everyone is doubting efficacy.  But the approved products are NG also?  Well if the pharma...
hoffbag - November 25, 2023

$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKIN

$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKING!   https://www.aviseanalytics.com/anavex2-73-a-potential...
AviseAnalytics - June 30, 2021

AVXL 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!

5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/ ...
AviseAnalytics - June 22, 2021

ALL ABOARD

Dont miss this train leaving the station.............
billybob22 - February 4, 2021

End of Month - September 2020

End of the Month (EOM) report for November 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.33 AVXL closed on 10...
R_J_ - December 2, 2020

End of Month - October 2020

End of the Month (EOM) report for October 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.90 AVXL closed on 09/30...
R_J_ - October 31, 2020
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc. is a Montney-focused oil and natural gas exploration and development company, with lands located in ...
View More »